News brief
On October 10, 2026, per AIPressRoom, Italian robotic microsurgery firm Medical Microinstruments raised $125 million in a Series D led by BioStar Capital to accelerate commercialization of its Symani Surgical System.
Connected profiles
Explore
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- aipressroom.com ↗Published Oct 10, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年10月10日，据AIPressRoom报道，意大利显微手术机器人公司Medical Microinstruments完成1.25亿美元D轮融资，由BioStar Capital领投，加速Symani手术系统商业化。